Risk factors of linezolid interruption in patients with multidrug-resistant tuberculosis receiving a linezolid-based treatment regimen

ZOU Liping, WU Guihui, LIANG Li, SHI Zhengyu, CHEN Qing, FU Li

PDF(910 KB)
PDF(910 KB)
Chinese Journal of Infection and Chemotherapy ›› 2022, Vol. 22 ›› Issue (6) : 702-707. DOI: 10.16718/j.1009-7708.2022.06.008
Original Article

Risk factors of linezolid interruption in patients with multidrug-resistant tuberculosis receiving a linezolid-based treatment regimen

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 22(6): 702-707 https://doi.org/10.16718/j.1009-7708.2022.06.008

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(910 KB)

Accesses

Citation

Detail
Sections
Recommended
沪ICP备11042064-1
Copyright © Chinese Journal of Infection and Chemotherapy, All Rights Reserved.
Address：12 Wulumuqi Zhong Road Shanghai, China　
Post Code：200040
Tel: 021-52888148　
　E-mail: cjic@fudan.edu.cn 或 hscjic@fudan.edu.cn
Powered by Beijing Magtech Co. Ltd.

/

〈 〉